Lung-derived bone morphogenetic proteins (BMPs) act as anti-metastatic signals in the lung, and lung metastatic breast cancer cells need to overcome their inhibitory effect to form metastasis (Fig. 4). This evidence concerns the gene CLN5 and breast cancer.